Specialist in the valuation of companies and intangible assets in the life sciences sector. Main areas of activity are strategic and objective company valuations, purchase price allocations (IFRS 3) and valuations for tax purposes. Extensive expertise in supporting national and international life sciences transactions and organiser of the annual KPMG Life Sciences Event.
Industry focus: pharmaceuticals, biotechnology, chemicals.